ScoreWhy is Genomma Lab Internacional SAB de CV ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 7.73% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 14.48% signifying low profitability per unit of shareholders funds
2
With ROE of 17.69%, it has a very expensive valuation with a 1.58 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -35.49%, its profits have risen by 57.9% ; the PEG ratio of the company is 0.2
3
Below par performance in long term as well as near term
- Along with generating -35.49% returns in the last 1 year, the stock has also underperformed Mexico IPC in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Genomma Lab Internacional SAB de CV for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Genomma Lab Internacional SAB de CV
-100.0%
52.70
34.28%
Mexico IPC
31.4%
1.71
18.32%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.89%
EBIT Growth (5y)
7.73%
EBIT to Interest (avg)
3.31
Debt to EBITDA (avg)
1.32
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
1.02
Tax Ratio
26.38%
Dividend Payout Ratio
52.17%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
22.18%
ROE (avg)
14.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.58
EV to EBIT
5.52
EV to EBITDA
5.02
EV to Capital Employed
1.41
EV to Sales
1.19
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
25.52%
ROE (Latest)
17.69%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 0.62% (YoY
CASH AND EQV(HY)
Highest at MXN 4,780.58 MM
-4What is not working for the Company
NET PROFIT(HY)
At MXN 789.03 MM has Grown at -38.92%
OPERATING PROFIT(Q)
Lowest at MXN 1,000.99 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 22.54 %
Here's what is working for Genomma Lab Internacional SAB de CV
Cash and Eqv
Highest at MXN 4,780.58 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by 0.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Genomma Lab Internacional SAB de CV
Net Profit
At MXN 789.03 MM has Grown at -38.92%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (MXN MM)
Operating Profit
Lowest at MXN 1,000.99 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (MXN MM)
Operating Profit Margin
Lowest at 22.54 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
